IR-Med IncOTCQB:IRME
- LAST PRICE0.8300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.5000/ 25
- Ask / Lots0.8600/ 10
- Open / Previous Close--- / 0.8300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IR-Med Inc | 58.7M | -20.1x | --- |
Baird Medical Investment Holdings Ltd | 59.2M | -3.1x | --- |
Modular Medical Inc | 58.1M | -2.6x | --- |
Medinotec Inc | 58.7M | -2,688.2x | --- |
Lucid Diagnostics Inc | 53.9M | -0.9x | --- |
Nutriband Inc | 53.4M | -5.9x | --- |
Company Information
IR-Med, Inc. is a development-stage medical device company. The Company is engaged in developing its technology through its subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with artificial intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time. The Company has three principal medical devices in development. Its product under development, PressureSafe, is a handheld optical monitoring device that is being developed to support early detection of pressure injuries (PI) to the skin and underlying tissue. DiaSafe is a handheld optical monitoring device that is being developed to support early detection of DFUs in lower limb skin and underlying tissue. Nobiotics is an otoscope designed to support physicians with an immediate indication as to whether a mid-ear infection (otitis media) is of a bacterial origin.
Contact Information
- Headquarters
- C/O ABOUDI LEGAL GROUP PLLC 745 5TH AVE, SUITE 500NEW YORK, NY, United States 10151
- Phone
- 646-768-4285
- Fax
- 916-720-0663
Executives
- Executive Chairman of the Board
- Oded Bashan
- Chief Executive Officer
- Ran Ziskind
- Chief Financial Officer
- Sharon Levkoviz
- Chief Technology Officer, Director
- Ronnie Klein
- Chief Development Officer
- Aharon Binur
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $58.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.7M |
IR-Med Inc does not pay a dividend. | |
Beta | 1.47 |
EPS | $-0.04 |
Book Value | $0.01 |
P/E Ratio | -20.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
